BSE · GENPHARMA

GENPHARMASEC LIMITED

Sector: Healthcare · ISIN: INE861N01036

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#3,274

of 5,084 stocks

▼ 141W

Peak #3,260 · 21 Sep 2026

GENPHARMASEC LIMITED, a microcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and has a subdued return on equity. Ownership as of Jun 2026.

Market Cap

62.02 Cr

P/E Ratio

112.00

P/B Ratio

0.94

ROE

0.85%

ROCE

2.43%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	49.71 Cr	55.43 Cr	39.83 Cr	32.64 Cr
Net Profit	-17.38 L	1.35 Cr	-83.20 L	-1.18 Cr
EPS	0.00	0.02	0.02	0.02
Operating Profit	65.67 L	2.33 Cr	-92.09 L	-57.08 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

29.98%

Public

70.02%

PUBLIC BREAKDOWN

Individuals

63.53%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
09 Jan 2024	Other	Right Issue of Equity Shares
25 May 2023	Other	E.G.M.
11 Apr 2019	Split	Stock Split From Rs.10/- to Rs.1/-
03 Aug 2016	Other	Reduction of Capital

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs